Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #52,301 to #52,350.
- Lymphocytopenia pathophysiology (3 revisions)
- Lymphocytopenia physical examination (3 revisions)
- Lymphocytopenia primary prevention (3 revisions)
- Lymphocytopenia risk factors (3 revisions)
- Lymphocytopenia surgery (3 revisions)
- Lymphoepithelioma CT (3 revisions)
- Lymphoepithelioma MRI (3 revisions)
- Lymphoepithelioma chest x ray (3 revisions)
- Lymphoepithelioma classification (3 revisions)
- Lymphoepithelioma cost-effectiveness of therapy (3 revisions)
- Lymphoepithelioma differential diagnosis (3 revisions)
- Lymphoepithelioma echocardiography or ultrasound (3 revisions)
- Lymphoepithelioma electrocardiogram (3 revisions)
- Lymphoepithelioma epidemiology and demographics (3 revisions)
- Lymphoepithelioma future or investigational therapies (3 revisions)
- Lymphoepithelioma historical perspective (3 revisions)
- Lymphoepithelioma laboratory tests (3 revisions)
- Lymphoepithelioma medical therapy (3 revisions)
- Lymphoepithelioma natural history (3 revisions)
- Lymphoepithelioma other diagnostic studies (3 revisions)
- Lymphoepithelioma other imaging findings (3 revisions)
- Lymphoepithelioma physical examination (3 revisions)
- Lymphoepithelioma primary prevention (3 revisions)
- Lymphoepithelioma risk factors (3 revisions)
- Lymphoepithelioma screening (3 revisions)
- Lymphoepithelioma secondary prevention (3 revisions)
- Lymphoepithelioma staging (3 revisions)
- Lymphoepithelioma surgery (3 revisions)
- Lymphogranuloma venereum case study one (3 revisions)
- Lymphogranuloma venereum cost-effectiveness of therapy (3 revisions)
- Lymphomatoid granulomatosis cost-effectiveness of therapy (3 revisions)
- Lymphomatoid granulomatosis future or investigational therapies (3 revisions)
- Lysosomal lipase (3 revisions)
- Lysyl hydroxylase (3 revisions)
- Lysyl oxidase (3 revisions)
- MAB21L2 (3 revisions)
- MACOP-B regimen (3 revisions)
- MACS (3 revisions)
- MADD (gene) (3 revisions)
- MAFA (gene) (3 revisions)
- MAFG (3 revisions)
- MAGEA11 (3 revisions)
- MAGEA3 (3 revisions)
- MAGED1 (3 revisions)
- MAGI2 (3 revisions)
- MAGI3 (3 revisions)
- MAGOH (3 revisions)
- MAK16 (3 revisions)
- MALT1 (3 revisions)
- MALT lymphoma case study one (3 revisions)